Cognetivity Neurosciences Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Cognetivity Neurosciences Ltd's estimated annual revenue is currently $3.5M per year.
- Cognetivity Neurosciences Ltd's estimated revenue per employee is $112,000
Employee Data
- Cognetivity Neurosciences Ltd has 31 Employees.
Cognetivity Neurosciences Ltd's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Account Manager | Reveal Email/Phone |
Cognetivity Neurosciences Ltd Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.9M | 44 | N/A | N/A | N/A |
#2 | $0.5M | 15 | -17% | $23M | N/A |
#3 | $0.3M | 4 | -60% | N/A | N/A |
#4 | $5.5M | 49 | 53% | N/A | N/A |
#5 | $120.2M | 687 | 84% | N/A | N/A |
#6 | $4.4M | 39 | -5% | N/A | N/A |
#7 | $5.2M | 46 | 59% | N/A | N/A |
#8 | $2.3M | 23 | N/A | N/A | N/A |
#9 | $19.3M | 138 | -4% | $68M | N/A |
#10 | $68.4M | 391 | -37% | N/A | N/A |
What Is Cognetivity Neurosciences Ltd?
Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease. Our patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis.
keywords:N/AN/A
Total Funding
31
Number of Employees
$3.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cognetivity Neurosciences Ltd News
2022-04-13 - Cognetivity Neurosciences Shines Member-based Spotlight on the Alzheimer's
Association Business Consortium
VANCOUVER, BC, April 20, 2022 /CNW/ - Cognetivity Neurosciences Ltd. ("Cognetivity" or the "Company") (CSE: CGN) (OTCQB: CGNSF) (FRA: 1UB),...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.2M | 31 | -11% | N/A |
#2 | $3.6M | 31 | 3% | N/A |
#3 | $5M | 31 | -52% | N/A |
#4 | $6.2M | 31 | -14% | N/A |
#5 | $6.2M | 31 | -3% | N/A |